Intravenous iron therapy: how far have we come? - PubMed (original) (raw)
Intravenous iron therapy: how far have we come?
Rodolfo Delfini Cançado et al. Rev Bras Hematol Hemoter. 2011.
Abstract
Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia (IDA) because of its effectiveness and low cost. But unfortunately in many iron deficient conditions, oral iron is a less than the ideal treatment mainly because of adverse events related to the gastrointestinal tract as well as the long course required to treat anemia and replenish body iron stores. The first iron product for intravenous use was high-molecular-weight iron dextran. However, dextran-containing intravenous iron preparations are associated with an elevated risk of anaphylactic reactions, which made physicians reluctant to prescribe intravenous iron in the treatment of iron deficiency anemia for many years. In 1999 and 2001, two new intravenous iron preparations (ferric gluconate and iron sucrose) were introduced into the market as safer alternatives to iron dextran. Over the last five years, three new intravenous iron dextran-free preparations have been developed and have better safety profiles than the more traditional intravenous compounds, as none require test doses and all these products are promising in respect to a more rapid replacement of body iron stores (15-60 minutes/infusion) as they can be given at higher doses (from 500 mg to more than 1000 mg/infusion). The purpose of this review is to discuss some pertinent issues in relation to the history, pharmacology, administration, efficacy, safety profile and toxicity of intravenous iron for the treatment of iron deficiency anemia.
Keywords: Anemia, iron-deficiency; Infusions, intravenous; Iron compounds; Iron deficiency.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interest
Similar articles
- Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia.
Friedrisch JR, Cançado RD. Friedrisch JR, et al. Rev Bras Hematol Hemoter. 2015 Nov-Dec;37(6):400-5. doi: 10.1016/j.bjhh.2015.08.012. Epub 2015 Oct 14. Rev Bras Hematol Hemoter. 2015. PMID: 26670403 Free PMC article. - The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
Qunibi WY. Qunibi WY. Arzneimittelforschung. 2010;60(6a):399-412. doi: 10.1055/s-0031-1296304. Arzneimittelforschung. 2010. PMID: 20648931 Review. - Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC, Geisser P. Macdougall IC, et al. Iran J Kidney Dis. 2013 Jan;7(1):9-22. Iran J Kidney Dis. 2013. PMID: 23314137 Review. - [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
Rottembourg J, Rostoker G. Rottembourg J, et al. Nephrol Ther. 2015 Dec;11(7):531-42. doi: 10.1016/j.nephro.2015.04.009. Epub 2015 Oct 20. Nephrol Ther. 2015. PMID: 26498106 Review. French. - Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Schröder O, et al. Am J Gastroenterol. 2005 Nov;100(11):2503-9. doi: 10.1111/j.1572-0241.2005.00250.x. Am J Gastroenterol. 2005. PMID: 16279906 Clinical Trial.
Cited by
- Nano-scale characterization of iron-carbohydrate complexes by cryogenic scanning transmission electron microscopy: Building the bridge to biorelevant characterization.
Digigow R, Burgert M, Luechinger M, Sologubenko A, Rzepiela AJ, Handschin S, Alston AEB, Flühmann B, Philipp E. Digigow R, et al. Heliyon. 2024 Aug 24;10(17):e36749. doi: 10.1016/j.heliyon.2024.e36749. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281449 Free PMC article. - Exploring progress in iron supplement formulation approaches for treating iron deficiency anemia through bibliometric and thematic analysis.
Kaur T, Upadhyay J, Nandave M, Alsayari A, Alshehri SA, Pukale S, Wahab S, Ahmad W, Rashid S, Ansari MN. Kaur T, et al. Heliyon. 2024 Apr 4;10(7):e29058. doi: 10.1016/j.heliyon.2024.e29058. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38623202 Free PMC article. Review. - Inpatient management of iron deficiency anemia in pediatric patients with inflammatory bowel disease: A single center experience.
Manokaran K, Spaan J, Cataldo G, Lyons C, Mitchell PD, Sare T, Zimmerman LA, Rufo PA. Manokaran K, et al. World J Clin Pediatr. 2024 Mar 9;13(1):89318. doi: 10.5409/wjcp.v13.i1.89318. eCollection 2024 Mar 9. World J Clin Pediatr. 2024. PMID: 38596440 Free PMC article. - Postoperative anemia in cardiac surgery patients: a narrative review.
Li MM, Miles S, Callum J, Lin Y, Karkouti K, Bartoszko J. Li MM, et al. Can J Anaesth. 2024 Mar;71(3):408-421. doi: 10.1007/s12630-023-02650-9. Epub 2023 Nov 28. Can J Anaesth. 2024. PMID: 38017198 Review. English. - Intravenous ferric carboxymaltose versus oral ferrous sulfate replacement in elderly patients after acute non-variceal gastrointestinal bleeding (FIERCE): protocol of a multicentre, open-label, randomised controlled trial.
Teutsch B, Váncsa S, Farkas N, Szakács Z, Vörhendi N, Boros E, Szabó I, Hágendorn R, Alizadeh H, Hegyi P, Erőss B. Teutsch B, et al. BMJ Open. 2023 Mar 14;13(3):e063554. doi: 10.1136/bmjopen-2022-063554. BMJ Open. 2023. PMID: 36918236 Free PMC article.
References
- Hersko C.Prevalence and causes of iron deficiency anaemia In: Beaumont C, Beris P, Beuzard Y, Brugnara C.Disorders of iron homeostasis, erythrocytes, erythropoiesis. Paris: European School of Haematology; 2006: 409-19
- Auerbach M, Ballard H.Clinical use of intravenous iron: administration, efficacy and safety. Am Soc Hematol Educ Program. 2010: 338-47 - PubMed
- Blaud P.[Sur les maladies chloropiques et sur un mode de traitement specifique dons ces affecions]. Rev Med Fr Etrang. 1832; 45: 357-67 French:
- Brugnara C, Beris P.Iron therapy In: Beaumont C, Beris P, Beuzard Y, Brugnara C.Disorders of erythropoiesis, erythrocytes and iron metabolism. Paris: European School of Haematology; 2009. p.512-28
LinkOut - more resources
Full Text Sources
Other Literature Sources